Alamo Group Inc
Change company Symbol lookup
Select an option...
ALG Alamo Group Inc
BCPC Balchem Corp
HE Hawaiian Electric Industries Inc
ASGN ASGN Inc
MAN ManpowerGroup Inc
APG APi Group Corp
CWST Casella Waste Systems Inc
FCFS Firstcash Holdings Inc
STVN Stevanato Group SpA
OSH Oak Street Health Inc
Go

Industrials : Machinery | Small Cap Blend
Company profile

Alamo Group Inc. is engaged in designing, manufacturing and servicing quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. The Company operates through two segments: Vegetation Management Division and Industrial Equipment Division. The Vegetation Management Division includes all its agricultural activities and mowing and forestry/tree care operations, including Morbark and Dutch Power business. The Industrial Equipment Division includes its vocational truck business and other industrial operations, such as excavators, vacuum trucks, street sweepers, and snow removal equipment. The Company sells its products primarily through a network of independent dealers and distributors to governmental end-users, related independent contractors, as well as to the agricultural and commercial turf markets. The Company operates approximately 29 plants in North America, South America, Europe and Australia.

Price
Delayed
$147.64
Day's Change
0.92 (0.63%)
Bid
--
Ask
--
B/A Size
--
Day's High
147.66
Day's Low
145.50
Volume
(Below Average)

Today's volume of 17,662 shares is on pace to be lower than ALG's 10-day average volume of 38,473 shares.

17,662

KRBP LAWSUIT ALERT: Levi & Korsinsky Notifies Kiromic BioPharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

1:01 pm ET October 3, 2022 (Newsfile) Print

New York, New York--(Newsfile Corp. - October 3, 2022) - Levi & Korsinsky, LLP notifies investors in Kiromic BioPharma, Inc. ("Kiromic" or the "Company") (NASDAQ: KRBP) of a class action securities lawsuit.

The lawsuit on behalf of Kiromic investors has been commenced in the the United States District Court for the Southern District of New York. This lawsuit is on behalf of a class consisting of persons and entities that purchased or otherwise acquired: (a) Kiromic common stock issued in connection with the Company's public offering that closed on July 2, 2021 and/or (b) Kiromic common stock between June 25, 2021 and August 13, 2021, both dates inclusive. Follow the link below to get more information and be contacted by a member of our team:

https://www.zlk.com/pslra-1/kiromic-lawsuit-submission-form?prid=32356&wire=5

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7091/139313_966902_logo.jpg





Cannot view this video? Visit:

https://www.youtube.com/watch?v=FgqHqz-1VT8

Kiromic BioPharma, Inc. NEWS - KRBP NEWS

CASE DETAILS: The complaint alleges that the registration statement and prospectus issued in connection with the Company's public offering that closed on July 2, 2021 (the "Offering Documents") failed to disclose that the Food and Drug Administration ("FDA") had, prior to the filing of these documents, imposed a clinical hold on the Company's Investigational New Drug ("IND") applications for its two new drug candidates. Given that the offering closed on July 2, 2021, more than thirty (30) days after the Company submitted the IND applications for its two immunotherapy product candidates, investors were assured that no clinical hold had been issued and clinical trials would commence.

WHAT THIS MEANS TO SHAREHOLDERS: If you suffered a loss in Kiromic during the relevant timeframe, you have until October 4, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. Discuss your rights with our legal team without cost or obligation.

PROTECT YOUR FINANCIAL INTERESTS: Complete this brief submission form https://www.zlk.com/pslra-1/kiromic-lawsuit-submission-form?prid=32356&wire=5 or call 212-363-7500 to discuss the case.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/139313

comtex tracking

COMTEX_415819150/2523/2022-10-03T13:01:04

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.